Picture EBD Group World of Partnering Opportunities 650x100px

Organisation › Details

Ono Pharmaceutical Co., Ltd. (TSE: 4528)

https://www.ono.co.jp

	Start	1995-10-01 existent
	Group	Ono Pharmaceutical (Group)
	Industry	pharmaceutical

	Region	Osaka
	Country	Japan
	Street	2-1-5 Doshomachi, Chuo-ku
	City	541-8526 Osaka
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2024-08-24

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Ono Pharmaceutical (Group)

[1] Systasy Bioscience GmbH. (7/31/24). "Press Release: Systasy Bioscience Announces Collaboration Agreement with Ono Pharmaceutical". Munich....
[2] Macomics Ltd.. (3/23/23). "Press Release: Macomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy"....
[3] PrecisionLife Ltd.. (12/14/22). "Press Release: PrecisionLife Enters into a Multi Target R&D Collaboration Agreement with Ono Pharmaceutical". Oxford....
[4] Memo Therapeutics AG. (11/1/22). "Press Release: Memo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology Targets". Schlieren....
[5] Neurimmune AG. (1/17/22). "Press Release: Neurimmune Expands Drug Discovery Collaboration with Ono Pharmaceutical in the Field of Neurodegenerative Diseases". Zürich....
[6] Numab Therapeutics AG. (3/30/20). "Press Release: Numab Therapeutics Expands Immuno-Oncology Research Alliance with Ono Pharmaceutical Co., Ltd.". Wädenswil (Zurich)....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]